528 related articles for article (PubMed ID: 11916485)
1. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
[TBL] [Abstract][Full Text] [Related]
3. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector.
Tsuda H; Wada T; Ito Y; Uchida H; Dehari H; Nakamura K; Sasaki K; Kobune M; Yamashita T; Hamada H
Mol Ther; 2003 Mar; 7(3):354-65. PubMed ID: 12668131
[TBL] [Abstract][Full Text] [Related]
4. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
[TBL] [Abstract][Full Text] [Related]
5. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors.
Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR
Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972
[TBL] [Abstract][Full Text] [Related]
6. A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritis.
Bakker AC; Van de Loo FA; Joosten LA; Bennink MB; Arntz OJ; Dmitriev IP; Kashentsera EA; Curiel DT; van den Berg WB
Gene Ther; 2001 Dec; 8(23):1785-93. PubMed ID: 11803398
[TBL] [Abstract][Full Text] [Related]
7. Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene.
Tsuda H; Wada T; Yamashita T; Hamada H
J Gene Med; 2005 Oct; 7(10):1322-34. PubMed ID: 15926193
[TBL] [Abstract][Full Text] [Related]
8. Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif.
Hiwasa K; Nagaya H; Terao S; Acharya B; Hamada K; Mizuguchi H; Gotoh A
Anticancer Res; 2012 Aug; 32(8):3137-40. PubMed ID: 22843884
[TBL] [Abstract][Full Text] [Related]
9. The alphavbeta5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses.
Nagel H; Maag S; Tassis A; Nestlé FO; Greber UF; Hemmi S
Gene Ther; 2003 Sep; 10(19):1643-53. PubMed ID: 12923563
[TBL] [Abstract][Full Text] [Related]
10. Targeting of high-capacity adenoviral vectors.
Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
[TBL] [Abstract][Full Text] [Related]
11. Improved gene transfer into renal carcinoma cells using adenovirus vector containing RGD motif.
Terao S; Acharya B; Suzuki T; Aoi T; Naoe M; Hamada K; Mizuguchi H; Gotoh A
Anticancer Res; 2009 Aug; 29(8):2997-3001. PubMed ID: 19661307
[TBL] [Abstract][Full Text] [Related]
12. Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors.
Kibbe MR; Murdock A; Wickham T; Lizonova A; Kovesdi I; Nie S; Shears L; Billiar TR; Tzeng E
Arch Surg; 2000 Feb; 135(2):191-7. PubMed ID: 10668880
[TBL] [Abstract][Full Text] [Related]
13. Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy.
Wang W; Zhu NL; Chua J; Swenson S; Costa FK; Schmitmeier S; Sosnowski BA; Shichinohe T; Kasahara N; Chen TC
J Neurosurg; 2005 Dec; 103(6):1058-66. PubMed ID: 16381193
[TBL] [Abstract][Full Text] [Related]
14. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524
[TBL] [Abstract][Full Text] [Related]
15. Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5/3 chimerism.
Volk AL; Rivera AA; Kanerva A; Bauerschmitz G; Dmitriev I; Nettelbeck DM; Curiel DT
Cancer Biol Ther; 2003; 2(5):511-5. PubMed ID: 14614316
[TBL] [Abstract][Full Text] [Related]
16. Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds.
Stoff A; Rivera AA; Banerjee NS; Mathis JM; Espinosa-de-los-Monteros A; Le LP; De la Torre JI; Vasconez LO; Broker TR; Richter DF; Stoff-Khalili MA; Curiel DT
Wound Repair Regen; 2006; 14(5):608-17. PubMed ID: 17014674
[TBL] [Abstract][Full Text] [Related]
17. Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs.
Logunov DY; Zubkova OV; Karyagina-Zhulina AS; Shuvalova EA; Karpov AP; Shmarov MM; Tutykhina IL; Alyapkina YS; Grezina NM; Zinovieva NA; Ernst LK; Gintsburg AL; Naroditsky BS
J Virol; 2007 Sep; 81(18):9641-52. PubMed ID: 17596306
[TBL] [Abstract][Full Text] [Related]
18. Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide.
Koizumi N; Mizuguchi H; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
Biochim Biophys Acta; 2001 Nov; 1568(1):13-20. PubMed ID: 11731080
[TBL] [Abstract][Full Text] [Related]
19. Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob.
Koizumi N; Mizuguchi H; Utoguchi N; Watanabe Y; Hayakawa T
J Gene Med; 2003 Apr; 5(4):267-76. PubMed ID: 12692861
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.
Brüning A; Köhler T; Quist S; Wang-Gohrke S; Moebus VJ; Kreienberg R; Runnebaum IB
Hum Gene Ther; 2001 Mar; 12(4):391-9. PubMed ID: 11242531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
